| scholarly article | Q13442814 |
| P2093 | author name string | Michael G Brattain | |
| Wensheng Liu | |||
| Rajinder S Sawhney | |||
| P2860 | cites work | Components of a new human protein kinase signal transduction pathway | Q24319086 |
| Primary Structure of BMK1: A New Mammalian MAP Kinase | Q24324142 | ||
| BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C | Q24532869 | ||
| FAK integrates growth-factor and integrin signals to promote cell migration | Q28144169 | ||
| MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion | Q28180881 | ||
| Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray | Q28198214 | ||
| Isolation of MEK5 and differential expression of alternatively spliced forms | Q28285099 | ||
| Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor | Q28286729 | ||
| Focal adhesion kinase: the first ten years | Q28609173 | ||
| Focal adhesion kinase: in command and control of cell motility | Q29615192 | ||
| Integrating adhesion, protrusion, and contraction during cell migration | Q30440890 | ||
| Focal adhesion kinase: targeting adhesion signaling pathways for therapeutic intervention | Q30445536 | ||
| Integrin cytoplasmic domain-binding proteins | Q34052642 | ||
| Role of the BMK1/ERK5 signaling pathway: lessons from knockout mice | Q34363614 | ||
| Role of integrins in cell invasion and migration | Q35084782 | ||
| Therapeutic antagonists and conformational regulation of integrin function | Q35209992 | ||
| The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors | Q36117485 | ||
| An inhibitory role for FAK in regulating proliferation: a link between limited adhesion and RhoA-ROCK signaling | Q36118275 | ||
| Monitoring fibroblast behavior in tissue culture with an applied electric field | Q36262812 | ||
| MAPK signalling: ERK5 versus ERK1/2. | Q36553050 | ||
| Specific induction of pp125 focal adhesion kinase in human breast cancer | Q36615312 | ||
| A morphological biosensor for mammalian cells | Q36757367 | ||
| Cell-matrix adhesion | Q36902965 | ||
| Micromotion of mammalian cells measured electrically | Q37590362 | ||
| Combination of integrin siRNA and irradiation for breast cancer therapy | Q40211567 | ||
| In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3. | Q40223991 | ||
| Integrin alphaVbeta3 contains a receptor site for resveratrol | Q40264413 | ||
| Global gene expression analysis of ERK5 and ERK1/2 signaling reveals a role for HIF-1 in ERK5-mediated responses. | Q40273686 | ||
| Integrin alpha2-mediated ERK and calpain activation play a critical role in cell adhesion and motility via focal adhesion kinase signaling: identification of a novel signaling pathway | Q40319949 | ||
| The unique C-terminal tail of the mitogen-activated protein kinase ERK5 regulates its activation and nuclear shuttling. | Q40490843 | ||
| Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion | Q40494312 | ||
| Autocrine transforming growth factor alpha regulates cell adhesion by multiple signaling via specific phosphorylation sites of p70S6 kinase in colon cancer cells. | Q40526630 | ||
| Bimolecular interaction of insulin-like growth factor (IGF) binding protein-2 with alphavbeta3 negatively modulates IGF-I-mediated migration and tumor growth. | Q40590800 | ||
| A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancer | Q40704741 | ||
| Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone | Q40713735 | ||
| Prostatic carcinoma cell migration via alpha(v)beta3 integrin is modulated by a focal adhesion kinase pathway | Q40961756 | ||
| Integrin alpha2 and extracellular signal-regulated kinase are functionally linked in highly malignant autocrine transforming growth factor-alpha-driven colon cancer cells | Q42438812 | ||
| Differences in sensitivity of biological functions mediated by epidermal growth factor receptor activation with respect to endogenous and exogenous ligands | Q42512178 | ||
| Activation of either ERK1/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton | Q42816454 | ||
| Characterization of the MEK5-ERK5 module in human neutrophils and its relationship to ERK1/ERK2 in the chemotactic response. | Q45069674 | ||
| Breast adenocarcinoma cell adhesion to the vascular subendothelium in whole blood and under flow conditions: effects of alphavbeta3 and alphaIIbbeta3 antagonists | Q45243204 | ||
| Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer | Q77603503 | ||
| P433 | issue | 1 | |
| P921 | main subject | cell adhesion | Q187640 |
| P304 | page(s) | 152-161 | |
| P577 | publication date | 2009-04-01 | |
| P1433 | published in | Journal of Cellular Physiology | Q1524270 |
| P1476 | title | A novel role of ERK5 in integrin-mediated cell adhesion and motility in cancer cells via Fak signaling | |
| P478 | volume | 219 |
| Q49798105 | Benzidine Induces Epithelial-Mesenchymal Transition of Human Bladder Cancer Cells through Activation of ERK5 Pathway |
| Q42117588 | Characterization of the role of RILP in cell migration |
| Q43811757 | Cytoskeletal reorganization mediates fluid shear stress-induced ERK5 activation in osteoblastic cells |
| Q21284312 | DIPSBC--data integration platform for systems biology collaborations |
| Q98771160 | ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer |
| Q39418708 | ERK5 regulates invasiveness of osteosarcoma by inducing MMP-9. |
| Q37722089 | Effect of ART1 on the proliferation and migration of mouse colon carcinoma CT26 cells in vivo |
| Q37442141 | Extracellular signal regulated kinase 5 mediates signals triggered by the novel tumor promoter palytoxin |
| Q90122397 | Extracellular signal regulated kinase 5 promotes cell migration, invasion and lung metastasis in a FAK-dependent manner |
| Q61798865 | Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells |
| Q33789414 | Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis |
| Q64065870 | Impact of ERK5 on the Hallmarks of Cancer |
| Q37467189 | Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development. |
| Q33917578 | Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer |
| Q38791344 | MAP Kinases and Prostate Cancer |
| Q38828361 | MAPK7 gene controls proliferation, migration and cell invasion in osteosarcoma |
| Q26866383 | MEK5/ERK5 pathway: the first fifteen years |
| Q37651604 | MEKK2 regulates focal adhesion stability and motility in invasive breast cancer cells. |
| Q38962538 | Modulation of ERK5 is a novel mechanism by which Cdc42 regulates migration of breast cancer cells. |
| Q92082570 | Mutations in the ND2 Subunit of Mitochondrial Complex I Are Sufficient to Confer Increased Tumorigenic and Metastatic Potential to Cancer Cells |
| Q39116456 | Oncogenic signaling of MEK5-ERK5. |
| Q51283531 | Optimal AraC-Cytotoxicity to AML Cells Requires ERK5 Activity. |
| Q24299360 | Pharmacological Inhibition of BMK1 Suppresses Tumor Growth through Promyelocytic Leukemia Protein |
| Q36502685 | Phosphorylation of BMK1 induces prostatic carcinoma cell proliferation by promoting entry into the S phase of the cell cycle |
| Q41905885 | Targeting the BMK1 MAP kinase pathway in cancer therapy. |
| Q54325437 | The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma. |
| Q27023876 | The roles of PIKE in tumorigenesis |
| Q51337382 | The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5. |
Search more.